219 related articles for article (PubMed ID: 20651982)
41. Transcriptome analysis upon potassium usnate exposure reveals ATF3-induced apoptosis in human gastric and colon cancer cells.
Yoo KH; Kim DH; Oh S; Park MS; Kim H; Ha HH; Cho SH; Chung IJ; Bae WK
Phytomedicine; 2021 Oct; 91():153655. PubMed ID: 34388563
[TBL] [Abstract][Full Text] [Related]
42. Induction of activating transcription factor 3 by anoxia is independent of p53 and the hypoxic HIF signalling pathway.
Ameri K; Hammond EM; Culmsee C; Raida M; Katschinski DM; Wenger RH; Wagner E; Davis RJ; Hai T; Denko N; Harris AL
Oncogene; 2007 Jan; 26(2):284-9. PubMed ID: 16847457
[TBL] [Abstract][Full Text] [Related]
43. Activating transcription factor 3 is a novel repressor of the nuclear factor erythroid-derived 2-related factor 2 (Nrf2)-regulated stress pathway.
Brown SL; Sekhar KR; Rachakonda G; Sasi S; Freeman ML
Cancer Res; 2008 Jan; 68(2):364-8. PubMed ID: 18199529
[TBL] [Abstract][Full Text] [Related]
44. The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesis.
Wang A; Arantes S; Yan L; Kiguchi K; McArthur MJ; Sahin A; Thames HD; Aldaz CM; Macleod MC
BMC Cancer; 2008 Sep; 8():268. PubMed ID: 18808719
[TBL] [Abstract][Full Text] [Related]
45. Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells.
Mansouri A; Ridgway LD; Korapati AL; Zhang Q; Tian L; Wang Y; Siddik ZH; Mills GB; Claret FX
J Biol Chem; 2003 May; 278(21):19245-56. PubMed ID: 12637505
[TBL] [Abstract][Full Text] [Related]
46. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
47. ATF3 plays a key role in Kdo2-lipid A-induced TLR4-dependent gene expression via NF-κB activation.
Kim EY; Shin HY; Kim JY; Kim DG; Choi YM; Kwon HK; Rhee DK; Kim YS; Choi S
PLoS One; 2010 Dec; 5(12):e14181. PubMed ID: 21152039
[TBL] [Abstract][Full Text] [Related]
48. Prostaglandin F2α induces expression of activating transcription factor 3 (ATF3) and activates MAPK signaling in the rat corpus luteum.
Guo N; Meng C; Bai W; Wei Q; Shi F; Davis JS; Mao D
Acta Histochem; 2015 Mar; 117(2):211-8. PubMed ID: 25614048
[TBL] [Abstract][Full Text] [Related]
49. Induction of LRF-1/ATF3 by vasopressin in hepatocytes: role of MAP kinases.
Sandnes D; Müller KM; Akhtar K; Johansen EJ; Christoffersen T; Thoresen GH
Cell Physiol Biochem; 2010; 25(4-5):523-32. PubMed ID: 20332633
[TBL] [Abstract][Full Text] [Related]
50. The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway.
Wu YJ; Muldoon LL; Neuwelt EA
J Pharmacol Exp Ther; 2005 Feb; 312(2):424-31. PubMed ID: 15496615
[TBL] [Abstract][Full Text] [Related]
51. The spliceosome inhibitors isoginkgetin and pladienolide B induce ATF3-dependent cell death.
Vanzyl EJ; Sayed H; Blackmore AB; Rick KRC; Fernando P; McKay BC
PLoS One; 2020; 15(12):e0224953. PubMed ID: 33370278
[TBL] [Abstract][Full Text] [Related]
52. Indoxyl sulfate upregulates the cannabinoid type 1 receptor gene via an ATF3/c-Jun complex-mediated signaling pathway in the model of uremic cardiomyopathy.
Hsu YJ; Hsu SC; Chang YL; Huang SM; Shih CC; Tsai CS; Lin CY
Int J Cardiol; 2018 Feb; 252():128-135. PubMed ID: 29203210
[TBL] [Abstract][Full Text] [Related]
53. Peroxiredoxin I plays a protective role against cisplatin cytotoxicity through mitogen activated kinase signals.
Ma D; Warabi E; Yanagawa T; Kimura S; Harada H; Yamagata K; Ishii T
Oral Oncol; 2009 Dec; 45(12):1037-43. PubMed ID: 19692293
[TBL] [Abstract][Full Text] [Related]
54. Expression of the activating transcription factor 3 prevents c-Jun N-terminal kinase-induced neuronal death by promoting heat shock protein 27 expression and Akt activation.
Nakagomi S; Suzuki Y; Namikawa K; Kiryu-Seo S; Kiyama H
J Neurosci; 2003 Jun; 23(12):5187-96. PubMed ID: 12832543
[TBL] [Abstract][Full Text] [Related]
55. Transcriptional regulation of activating transcription factor 3 involves the early growth response-1 gene.
Bottone FG; Moon Y; Alston-Mills B; Eling TE
J Pharmacol Exp Ther; 2005 Nov; 315(2):668-77. PubMed ID: 16079301
[TBL] [Abstract][Full Text] [Related]
56. Role of ATF3 in synergistic cancer cell killing by a combination of HDAC inhibitors and agonistic anti-DR5 antibody through ER stress in human colon cancer cells.
Liu J; Edagawa M; Goshima H; Inoue M; Yagita H; Liu Z; Kitajima S
Biochem Biophys Res Commun; 2014 Mar; 445(2):320-6. PubMed ID: 24530917
[TBL] [Abstract][Full Text] [Related]
57. PKCδ regulates death receptor 5 expression induced by PS-341 through ATF4-ATF3/CHOP axis in human lung cancer cells.
Xu L; Su L; Liu X
Mol Cancer Ther; 2012 Oct; 11(10):2174-82. PubMed ID: 22848091
[TBL] [Abstract][Full Text] [Related]
58. Butein sensitizes HeLa cells to cisplatin through the AKT and ERK/p38 MAPK pathways by targeting FoxO3a.
Zhang L; Yang X; Li X; Li C; Zhao L; Zhou Y; Hou H
Int J Mol Med; 2015 Oct; 36(4):957-66. PubMed ID: 26310353
[TBL] [Abstract][Full Text] [Related]
59. Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, IressaR) and chemotherapeutic agents in human lung cancer cells.
Ko JC; Ciou SC; Cheng CM; Wang LH; Hong JH; Jheng MY; Ling ST; Lin YW
Carcinogenesis; 2008 Jul; 29(7):1448-58. PubMed ID: 18544565
[TBL] [Abstract][Full Text] [Related]
60. Cisplatin potentiates 1,25-dihydroxyvitamin D3-induced apoptosis in association with increased mitogen-activated protein kinase kinase kinase 1 (MEKK-1) expression.
Hershberger PA; McGuire TF; Yu WD; Zuhowski EG; Schellens JH; Egorin MJ; Trump DL; Johnson CS
Mol Cancer Ther; 2002 Aug; 1(10):821-9. PubMed ID: 12492115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
